dad trial: combining sacituzumab govitecan and ev for the treatment of bladder cancer
Published 8 months ago • 143 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
5:44
dad: sacituzumab govetican enfortumab vedotin as a 2l therapy for muc
-
4:21
sacituzumab govitecan plus enfortumab vedotin in advanced urothelial cancer
-
4:21
sacituzumab govitecan plus enfortumab vedotin for treatment of advanced urothelial cancer
-
3:58
liquid biopsy for the diagnosis and treatment of bladder cancer
-
1:00
trial of durvalumab for bladder cancer
-
3:38
breakthroughs in urothelial cancer treatment at esmo 2023
-
2:04
unmet need in bladder cancer
-
2:22
keynote-057: extended follow-up of pembrolizumab in bladder cancer
-
2:29
bladder cancer treatment updates by prof. jones
-
53:23
bladder cancer tests, diagnosis and recurrence
-
1:33
ambassador: pembrolizumab for locally advanced bladder cancer
-
1:00
adjuvant pembrolizumab for bladder cancer
-
1:53
discussing recent advances and clinical trials in bladder cancer
-
1:28
immune checkpoint inhibitors and sitravatinib in bladder cancer
-
1:55
durvalumab monotherapy for patients with bcg-unresponsive carcinoma-in-situ bladder cancer
-
31:06
bladder cancer | 2022 oneoncology conference
-
2:41
mri advances, office biopsies, and bladder cancer treatment and staging | backtable urology clips
-
6:42
adjuvant pembrolizumab: the ambassador trial - bladder cancer video library
-
6:38
case 2: exciting new treatment for cis-ineligible bladder cancer